Senior insider sale
General Counsel at MEREO BIOPHARMA GROUP PLC — senior position signals high conviction
$305.8K
77.31K shares
What this filing means
SERMON CHARLES plans to sell 77.31K shares of MEREO BIOPHARMA GROUP PLC valued at approximately $305.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/12/2024ACC: 0000950170-24-105905
Officer· General Counsel
Since Feb 2026
77.31K
Shares to sell
$305.8K
Approx. market value
65.60K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Same Day Cashless Exercise and Sale
Equity Compensation
9/12/2024
65.60KTotal acquired65.60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/12/2024 | Same Day Cashless Exercise and Sale Equity Compensation | 65.60K | — |
| Total | 65.60K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
32.19K
Market value
$109.2K
6/26/2024
—Completed
Units to sell
14.20K
Market value
$52.5K
6/25/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
30.93K
Market value
$144.1K
9/12/2024
Total
Units
77.31K
Value
$305.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/26/2024 | 32.19K | $109.2K | — | Completed |
6/25/2024 | 14.20K | $52.5K | — | Completed |
| Planned — Approximate Date | ||||
9/12/2024 | 30.93K | $144.1K | NASDAQ | Planned |
| Total | 77.31K | $305.8K | ||